Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein e-deficient mice

Michael R. Preusch, Nicholas Ieronimakis, Errol S. Wijelath, Sara Cabbage, Jerry Ricks, Florian Bea, Morayma Reyes, Joanne van Ryn, Michael E. Rosenfeld

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint Dive into the research topics of 'Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein e-deficient mice'. Together they form a unique fingerprint.

Medicine & Life Sciences